Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veoneer publishes 2020 Annual Report on Form 10-K

Stockholm, Sweden, February 19, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), has filed its 2020 Annual Report on Form 10-K with the Securities and Exchange Commission (SEC).The 2020 Annual Report on Form 10-K is available at the SEC Edgar website: www.sec.gov and on Veoneer’s web site veoneer.com.Veoneer has also published its 2020 Sustainability Report on Veoneer’s web site veoneer.com For more information please contact:Thomas Jönsson, EVP Communications & IR, thomas.jonsson@veoneer.com, tel +46 (0)8 527 762 27 Veoneer, Inc. is a worldwide

Konecranes Plc - Managers' transactions - Topi Tiitola

Konecranes Plc - Managers' transactions - Topi Tiitola____________________________________________ Person subject to the notification requirementName: Tiitola, TopiPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145011_210____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 36 Unit price: 36.5574 EUR

Konecranes Plc - Managers' transactions - Juha Pankakoski

Konecranes Plc - Managers' transactions - Juha Pankakoski____________________________________________ Person subject to the notification requirementName: Pankakoski, JuhaPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145010_209____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 59 Unit price: 36.5574

Plasma oxalate and kidney function are correlated in patients with primary hyperoxaluria with maintained kidney function – Data from three placebo‑controlled studies published

Stockholm – 19 February 2021. OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of an article in Pediatric Nephrology, on the significant correlation between plasma oxalate and kidney function in three controlled clinical trials with PH patients.Primary hyperoxaluria is a rare autosomal recessive inherited disorder of glyoxylate metabolism that causes an endogenous overproduction of oxalate. Oxalate cannot be degraded in humans and is mostly eliminated by the kidneys. The oxalate

Konecranes Plc - Managers' transactions - Mika Mahlberg

Konecranes Plc - Managers' transactions - Mika Mahlberg____________________________________________ Person subject to the notification requirementName: Mahlberg, MikaPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145011_211____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 29 Unit price: 36.5574 EUR

Konecranes Plc - Managers' transactions - Timo Leskinen

Konecranes Plc - Managers' transactions - Timo Leskinen____________________________________________ Person subject to the notification requirementName: Leskinen, TimoPosition: Other senior managerIssuer: Konecranes PlcLEI: 549300EF0CDEQZBMA096 Notification type: INITIAL NOTIFICATIONReference number: 549300EF0CDEQZBMA096_20210219145014_212____________________________________________ Transaction date: 2021-02-18Venue: XHELInstrument type: SHAREISIN: FI0009005870Nature of the transaction: ACQUISITION Transaction details(1): Volume: 80 Unit price: 36.5574 EUR

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

European Lingerie Group AB informs on new terms of the Standstill Agreement

European Lingerie Group AB (“ELG” or “Company” and together with its subsidiaries from time to time, the “Group”) has previously announced that on 29 July 2020, ELG and its principal shareholders reached a standstill agreement and signed a standstill letter (“Standstill Letter”) with certain holders of the Bonds, today representing over 60 per cent of the Total Nominal Amount of the Bonds (the “Bondholder Committee“), regarding ELG’s defaults under the Terms and Conditions and also announced a cooperation between ELG and the Bondholder Committee to explore and execute a potential

#21-68 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-67 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Autoliv announces Annual Stockholders Meeting and publishes Annual and Sustainability Reports for 2020

(Stockholm, Sweden, February 19, 2021) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, will host a virtual-only Annual Stockholder Meeting on May 12, 2021 and has today filed its 2020 Annual Report on Form 10-K with the Securities and Exchange Commission (SEC).Annual Stockholders Meeting The 2021 Annual Stockholders Meeting of Autoliv, Inc. shall be held on Wednesday, May 12, 2021. To support the health and well-being of our employees, stockholders, and our community, our board of directors has decided that the meeting will be virtual, via

Metso Outotec Corporation: Managers' transactions – Pekka Vauramo

Metso Outotec Corporation’s stock exchange release on February 19, 2021, at 05:00 p.m. EETMetso Outotec Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso Outotec's shares. Person subject to the notification requirementName: Vauramo, PekkaPosition: Chief Executive Officer Initial NotificationReference number: 549300R0VN9C371W0E07_20210219150046_200 IssuerName:

Metso Outotec Corporation: Managers' transactions – Kari Stadigh

Metso Outotec Corporation’s stock exchange release on February 19, 2021, at 04:00 p.m. EETMetso Outotec Corporation has received the following disclosure under EU Market Abuse Regulation No 596/2014, regarding managers' or their closely associated persons' transactions with Metso Outotec's shares. Person subject to the notification requirementName: Stadigh, KariPosition: Member of the Board Initial NotificationReference number: 549300R0VN9C371W0E07_20210219085116_3 IssuerName: Metso

Lifco acquires German Kentzler-Kaschner Dental GmbH

Lifco  has signed an agreement to acquire a majority of the shares in German Kentzler-Kaschner Dental GmbH. The company sells consumable products to the dental industry, mainly in Germany. In 2020, Kentzler-Kaschner Dental reported net sales of approximately MEUR 3.6. The business is based in Ellwangen, southern Germany and has 20 employees. The company will be consolidated in Business Area Dental. The consolidation is expected to take place in March 2021. The acquisition will not have any significant effect on Lifco’s earnings or financial

Nightingale intends to launch an initial public offering and listing on Nasdaq First North Growth Market Finland

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nightingale Health Ltd (“Nightingale” or the “Company”), a company offering a health data platform that detects disease risks, announces its intention to proceed with an Initial Public Offering (“IPO” or “Offering”) and listing of its shares on Nasdaq First North Growth Market Finland. With its health data platform, the Company

Outokumpu – Manager transaction: Tamara Weinert

Outokumpu OyjStock exchange releaseManager transactionFebruary 19, 2021 at 3.30 pm EETOutokumpu – Manager transaction: Tamara Weinert Outokumpu has received a notification from Tamara Weinert, member of the Leadership Team, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name of the manager Tamara WeinertPosition in the issuer Member of the Leadership TeamIssuer Outokumpu OyjIssuer’s LEI reference 5493009YRUJJDCFF0R80

OrganoClick signs agreement with leading nonwoven manufacturer

OrganoClick has signed a 5-year frame work agreement with a leading nonwoven manufacturer for supply of OrganoClick’s biobased binders. The estimated value of the contract is around SEK 30 million per year when the biobinder has been fully implemented in the customers production.”This agreement is a great milestone for OrganoClick. We have worked with this project for more than two years and are now changing from development to full scale production. Our focus will now be on making ourselves ready for supplying this key customer with our biobased binders which replaces their current plastic

Asetek Liquid Cooling Technology is at the Heart of SAPPHIRE’s New TOXIC AMD RADEON™ RX 6900 XT Limited Edition Graphics Card with Hybrid GPU Cooler

Aalborg, Denmark – February 19, 2021 –– Asetek, the creator of the all-in-one liquid cooler and the global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, announced its liquid cooling technology is at the heart of the Hybrid GPU Cooler that new OEM Partner SAPPHIRE Technology has released with its TOXIC AMD RADEON™ RX 6900 XT Limited Edition Graphics Card. Liquid cooling is more critical than ever as AMD Radeon™ RX 6900 XT series GPUs have the ability to draw up to 400 Watts of power, driving core frequencies to 2360 MHz and beyond. With the SAPPHIRE TOXIC AMD RADEON™

Vectura and Zengun in continued cooperation regarding Forskaren in Hagastaden.

The cooperation that was initiated during the summer of 2020 with joint efforts on the design work and project planning now enters the next phase with the signing of a construction contract. The contract includes further detailed design work, procurements, construction, building commissioning and handover. With its distinct architecture and high ambitions for the project, such as certifying the project in accordance with LEED Platinum v.4 and WELL Gold, Forskaren is sure to be a landmark and a destination in the new urban development area Hagastaden. The project handover is planned to take

Adapteo Plc - Managers' Transactions – Peter Nilsson

Adapteo Plc Managers’ transactions 19 February 2021 at 2:00 p.m. CET ____________________________________________ Person subject to the notification requirement Name: Peter Nilsson by Poleved Industrial Performance ABPosition: Member of the Board/Deputy member(X) Legal person Issuer: AdaptLEI: 549300PDEXOKMLMDNZ32 Notification type: INITIAL NOTIFICATIONReference number: 549300PDEXOKMLMDNZ32_20210219085410_8 ____________________________________________ Transaction date: 2021-02-15Venue: NASDAQ STOCKHOLM AB (XSTO)Instrument type: SHAREISIN: F14000383898

Delisting of shares from Nasdaq Stockholm

As communicated by Recipharm AB (publ) (“Recipharm”) by way of a press release published on 15 February 2021, the board of directors of Recipharm has applied for delisting of Recipharm’s B-shares from Nasdaq Stockholm. Today, Nasdaq Stockholm approved the application and resolved that the last trading day will be 5 March 2021.   For further information, please contact:Anders G. Carlberg, chairman of the independent board of RecipharmBy phone: +46 70-543 75 76 The information was submitted for publication, through the agency of the contact person set out above, at 2:00 pm CET on

Hoist Finance Capital Markets Day 25 February 2021

Hoist Finance is pleased to invite investors, analysts, media and other stakeholders to a virtual live streamed Capital Markets Day on Thursday February 25 from 13:00 to approximately 16:30 CET. The executive management team will give an update on the strategy and financial targets, as well as ambitions for the coming years with a continued focus on sustainable profitability in a growing market. Furthermore, the management team will give an in-depth presentation of the four business lines: Digital, Contact Centre Operations, Secured Assets and Retail Banking. Enter this link to follow

Our Group ICT organisation is searching for an ICT Application Specialist to join our professional international team

The future is being created today. At Kiilto, we invest in the future every day by promoting occupational wellbeing, encouraging innovation and making our operations more and more sustainable. We are guided by the desire to be an environmental leader, using our expertise to create success stories for our customers. We are local, innovative and insightful. Would you like to add your own chapter to our hundred-year story of growth?     Our Group ICT organisation is searching for an  ICT APPLICATION SPECIALIST to join our professional international team   As an Application

Sedana Medical submits application for market approval in UK

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane) for inhaled sedation in intensive care in the UK.“Through this application, we cover another important European market ahead of our upcoming launch. If all goes well, we expect to be able to launch in the second half of 2021 in the first 15 European countries for which we have already submitted an application. In the UK, we expect to be able to launch in the first half of 2022," said Christer Ahlberg, CEO of Sedana

There are no items matching the current filter
There are no more items matching the current filter
Back to top